26 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 May 23
Report of Foreign Private Issuer
8:09am
of the International Society for Cell & Gene Therapy
Nes-Ziona, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company … a selected Elevator Pitch Presentation at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy (ISCT), which is taking place from
6-K
ENLV
Enlivex Therapeutics Ltd
31 May 23
Report of Foreign Private Issuer
8:09am
presentation and two additional poster presentations at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy, taking place from May
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
checkpoint inhibitor, in patients with advanced solid tumors.
In September 2022, at the European Society for Medical Oncology Congress 2022 we presented new
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Dec 22
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
8:05am
Presented new preclinical data at the European Society for Medical Oncology Congress 2022: Combining cisplatin with Allocetra™ led to a substantial
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
12 Sep 22
Report of Foreign Private Issuer
8:02am
at the European Society for Medical Oncology (ESMO) Congress 2022, which is taking place both virtually and in-person at the Paris Expo Porte de Versailles
6-K
EX-99.3
nm5uhibiipzquamrgnx5
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
6qopxq07qi8kr95is
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
xpj2j7oqb3js
6 Jun 22
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
4sfw30f 8sl51kg
31 May 22
Report of Foreign Private Issuer
8:04am
6-K
g8uio and4t
9 May 22
Report of Foreign Private Issuer
9:10am
6-K
EX-99.1
4z3wu 1oq
9 May 22
Report of Foreign Private Issuer
9:10am
6-K
EX-99.1
82vsk5745jb14hkxlum9
1 Mar 21
Report of Foreign Private Issuer
7:58am
6-K
EX-99.1
7285et
28 May 20
Report of Foreign Private Issuer
9:25am
6-K
1izm83g2
28 May 20
Report of Foreign Private Issuer
9:25am
6-K
pex 0csv68
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
j89vll1vk3d7b 5x9unb
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm